text: Some benign T cells can be CD10+
  In epithelial tumors
  Clear cell renal cell carcinoma (Clear cell RCC)
  CD10+ distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers. Chromophobe carcinoma and oncocytoma are CD10−.
  Pancreatic tumors
  Solid pseudopapillary tumours are CD10+.
  CD10+ differentiates mucinous cystic neoplasms (CD10+/CK20+) from intraductal papillary mucinous neoplasm of branch duct type (CD10−/CK20-).
  Cutaneous tumors
  CD10 may differentiate basal cell carcinoma (CD10 epithelial staining) from trichoblastoma (CD10 peritumoral stromal staining), basal cell carcinoma with follicular differentiation (CD10 stromal and epithelial staining) and squamous cell carcinoma (strong stromal staining).
  CD10 differentiates CD10+ atypical fibroxanthoma from CD10− spindle cell melanoma and sarcomatoid squamous cell carcinoma.
  Urothelial tumors express CD10 (42-67%).
  CD10 expression is strongly correlated with high tumor grade and stage in urothelial carcinoma of the bladder. CD10 may be associated with tumor progression in bladder cancer pathogenesis.
  In other tumors
  CD10 expression might be one of the characteristics of müllerian system-derived neoplastic mesenchymal cells.
  Normal endometrial stroma
  Endometrial stromal sarcoma (ESS) are CD10+ (Smooth muscle tumors are usually CD10−, but can be CD10+
  Malignant müllerian mixed tumor (MMMT)
  Müllerian adenosarcoma
  Uterine high-grade leiomyosarcoma
  Uterine rhabdomyosarcoma
  Vascular tumors
  Epithelioid hemangioendothelioma are mostly CD10+.
  Hemangioblastoma is usually CD10− (metastatic renal cell carcinoma is CD10+)